{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:12:51Z","timestamp":1783599171897,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1053\/j.jvca.2020.07.017","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T22:06:12Z","timestamp":1596060372000},"page":"378-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The 2019 ERS\/ESTS\/EACTS\/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma"],"prefix":"10.1053","volume":"35","author":[{"given":"Theresa A.","family":"Gelzinis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2020.07.017_bib0001","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.jvca.2020.07.017_bib0002","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1053\/j.jvca.2020.07.017_bib0003","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization classification of tumors of the pleura: Advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0004","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12199-007-0017-6","article-title":"Pathology of mesothelioma","volume":"13","author":"Inai","year":"2008","journal-title":"Environ Health Prev Med"},{"key":"10.1053\/j.jvca.2020.07.017_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5603\/ARM.2019.0051","article-title":"Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm","volume":"87","author":"Sayan","year":"2019","journal-title":"Adv Respir Med"},{"key":"10.1053\/j.jvca.2020.07.017_bib0006","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09059180.00007014","article-title":"Malignant pleural mesothelioma: History, controversy and future of a manmade epidemic","volume":"24","author":"R\u00f8e","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1053\/j.jvca.2020.07.017_bib0007","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The European mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/j.jvca.2020.07.017_bib0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/10408440802273156","article-title":"A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type","volume":"38","author":"Berman","year":"2008","journal-title":"Crit Rev Toxicol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0009","first-page":"718","article-title":"Latent period for malignant mesothelioma of occupational origin","volume":"34","author":"Lanphear","year":"1992","journal-title":"J Occup Med"},{"key":"10.1053\/j.jvca.2020.07.017_bib0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1183\/13993003.00091-2016","article-title":"Incidence and familial risk of pleural mesothelioma in Sweden: A national cohort study","volume":"48","author":"Ji","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1053\/j.jvca.2020.07.017_bib0011","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/ijc.27758","article-title":"Familial aggregation of malignant mesothelioma in former workers and residents of Wittenoom, Western Australia","volume":"132","author":"de Klerk","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1053\/j.jvca.2020.07.017_bib0012","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1200\/JCO.2018.36.15_suppl.8504","article-title":"Inherited predisposition to malignant mesothelioma (MM) due to mutations in DNA repair genes","volume":"36","author":"Hassan","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0013","doi-asserted-by":"crossref","first-page":"8564","DOI":"10.1200\/JCO.2018.36.15_suppl.8564","article-title":"Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma","volume":"36","author":"Panou","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0014","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/cam4.656","article-title":"Radiation-induced mesothelioma among long-term solid cancer survivors: A longitudinal analysis of SEER database","volume":"5","author":"Farioli","year":"2016","journal-title":"Cancer Med"},{"key":"10.1053\/j.jvca.2020.07.017_bib0015","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/(SICI)1097-0274(199711)32:5<445::AID-AJIM3>3.0.CO;2-R","article-title":"Pleural plaques as risk indicators for malignant pleural mesothelioma: A necropsy-based study","volume":"32","author":"Bianchi","year":"1997","journal-title":"Am J Ind Med"},{"key":"10.1053\/j.jvca.2020.07.017_bib0016","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/08958378.2015.1051640","article-title":"Are pleural plaques an appropriate endpoint for risk analyses?","volume":"27","author":"Maxim","year":"2015","journal-title":"Inhal Toxicol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/djs513","article-title":"Pleural plaques and the risk of pleural mesothelioma","volume":"105","author":"Pairon","year":"2013","journal-title":"J Nat Cancer Inst"},{"key":"10.1053\/j.jvca.2020.07.017_bib0018","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jtho.2019.05.044","article-title":"Lung cancer incidence and mortality with extended follow-up in the national lung screening trial","volume":"14","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0019","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00330-018-5533-9","article-title":"Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: A pilot study","volume":"29","author":"Gudmundsson","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0020","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1148\/rg.346130089","article-title":"Multimodality imaging for characterization, classification, and staging of malignant pleural mesothelioma","volume":"34","author":"Nickell","year":"2014","journal-title":"Radiographics"},{"key":"10.1053\/j.jvca.2020.07.017_bib0021","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1510\/icvts.2010.255893","article-title":"What is the best way to diagnose and stage malignant pleural mesothelioma?","volume":"12","author":"Zahid","year":"2011","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0022","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1378\/chest.14-0299","article-title":"Physician-based ultrasound-guided biopsy for diagnosing pleural disease","volume":"146","author":"Hallifax","year":"2014","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2020.07.017_bib0023","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/cncr.23034","article-title":"Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma","volume":"110","author":"Greillier","year":"2007","journal-title":"Cancer"},{"key":"10.1053\/j.jvca.2020.07.017_bib0024","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/JTO.0b013e31823e0667","article-title":"Pleural fluid cytological yield and visceral pleural invasion in patients with epithelioid malignant pleural mesothelioma","volume":"7","author":"Pinelli","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0025","doi-asserted-by":"crossref","first-page":"ii54","DOI":"10.1136\/thx.2010.137018","article-title":"Local anaesthetic thoracoscopy: British Thoracic Society pleural disease guideline 2010","volume":"65","author":"Rahman","year":"2010","journal-title":"Thorax"},{"key":"10.1053\/j.jvca.2020.07.017_bib0026","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejcdt.2013.08.012","article-title":"Diagnosis of exudative pleural effusion using ultrasound guided versus medical thoracoscopic pleural biopsy","volume":"62","author":"Mohamed","year":"2013","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"10.1053\/j.jvca.2020.07.017_bib0027","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/JTO.0b013e31824de2dc","article-title":"Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma","volume":"7","author":"B\u00f6l\u00fckbas","year":"2012","journal-title":"J Thoracic Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0028","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.21037\/jtd.2017.10.125","article-title":"The pathological and molecular diagnosis of malignant pleural mesothelioma: A literature review","volume":"10","author":"Al\u00ec","year":"2018","journal-title":"J Thorac Dis"},{"key":"10.1053\/j.jvca.2020.07.017_bib0029","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.jvca.2020.07.017_bib0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01254-2018","article-title":"Investigating unilateral pleural effusions: The role of cytology","volume":"52","author":"Arnold","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1053\/j.jvca.2020.07.017_bib0031","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 immunohistochemistry and p16 (CDKN2A) FISH in the diagnosis of malignant mesothelioma in effusion cytology specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0032","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.07.015","article-title":"The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell\/pleomorphic (sarcomatoid) carcinomas of the lung: Evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center","volume":"67","author":"Marchevsky","year":"2017","journal-title":"Human Pathol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0033","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jtho.2016.08.147","article-title":"The IASLC mesothelioma staging project: Proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma","volume":"11","author":"Nowak","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0034","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.jtho.2016.09.124","article-title":"The IASLC mesothelioma staging project: Proposals for the M descriptors and for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for mesothelioma","volume":"11","author":"Rusch","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0035","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/cncr.24886","article-title":"Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases","volume":"116","author":"Richards","year":"2010","journal-title":"Cancer"},{"key":"10.1053\/j.jvca.2020.07.017_bib0036","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","article-title":"Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma","volume":"260","author":"Sugarbaker","year":"2014","journal-title":"Ann Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0037","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/ejcts\/ezv422","article-title":"Specimen weight and volume: Important predictors of survival in malignant pleural mesothelioma","volume":"49","author":"Kircheva","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0038","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jtcvs.2005.11.044","article-title":"The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma","volume":"131","author":"Edwards","year":"2006","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0039","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0169-5002(03)92681-X","article-title":"P-714 The case for routine mediastinoscopy prior to radical resection of malignant pleural mesothelioma","volume":"41","author":"Pilling","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1053\/j.jvca.2020.07.017_bib0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.athoracsur.2016.06.069","article-title":"A multicenter study of volumetric computed tomography for staging malignant pleural mesothelioma","volume":"102","author":"Rusch","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0041","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jtcvs.2004.10.034","article-title":"Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications","volume":"129","author":"Erasmus","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0042","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.athoracsur.2009.05.022","article-title":"Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma","volume":"88","author":"Rice","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0043","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1445-2197.2009.05060.x","article-title":"Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy","volume":"79","author":"Alvarez","year":"2009","journal-title":"ANZ J Surg"},{"key":"10.1053\/j.jvca.2020.07.017_bib0044","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/JTO.0000000000000181","article-title":"Supplementary prognostic variables for pleural mesothelioma: A report from the IASLC staging committee","volume":"9","author":"Pass","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0045","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis","volume":"11","author":"Brims","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0046","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0047","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: Clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0048","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","article-title":"Does surgery improve survival of patients with malignant pleural mesothelioma? A multicenter retrospective analysis of 1365 consecutive patients","volume":"9","author":"Bovolato","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0049","doi-asserted-by":"crossref","first-page":"e18544","DOI":"10.1200\/jco.2013.31.15_suppl.e18544","article-title":"Clinical characteristics, treatment, and survival outcomes in malignant pleural mesothelioma: A institution experience in Turkey","volume":"31","author":"Kucukoner","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0050","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0169-5002(16)30212-4","article-title":"A feasibility study comparing (extended) pleurectomy decortication versus no pleurectomy decortication in the multimodality management of patients with malignant pleural mesothelioma: The MARS 2 study","volume":"91","author":"Lim","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1053\/j.jvca.2020.07.017_bib0051","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1378\/chest.108.3.754","article-title":"Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma","volume":"108","author":"Boutin","year":"1995","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2020.07.017_bib0052","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): A randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0053","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A feasibility study evaluating surgery for mesothelioma after radiation therapy: The \u201cSMART\u201d approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0054","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma","volume":"34","author":"Rimner","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0055","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2020.07.017_bib0056","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/S1470-2045(18)30100-1","article-title":"Novel therapies for malignant pleural mesothelioma","volume":"19","author":"Scherpereel","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0057","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1470-2045(17)30169-9","article-title":"Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): Preliminary results from a non-randomised, open-label, phase 1b trial","volume":"18","author":"Alley","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0058","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(18)30765-4","article-title":"Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): A multicentre, open-label, randomised, non-comparative, phase 2 trial","volume":"20","author":"Scherpereel","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0059","doi-asserted-by":"crossref","first-page":"562","DOI":"10.21037\/tlcr.2018.10.02","article-title":"Combined modality treatment in mesothelioma: A systemic literature review with treatment recommendations","volume":"7","author":"De Bondt","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1053\/j.jvca.2020.07.017_bib0060","article-title":"Radical multimodality therapy for malignant pleural mesothelioma","volume":"1","author":"Abdel-Rahman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.jvca.2020.07.017_bib0061","first-page":"2229","article-title":"Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients","volume":"26","author":"Gelhorn","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.1053\/j.jvca.2020.07.017_bib0062","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.jtho.2018.04.034","article-title":"revised modified response evaluation criteria in solid tumors for assessment of response in malignant pleural mesothelioma (version 1.1)","volume":"13","author":"Armato","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0063","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(14)60418-9","article-title":"Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): An open-label, randomised, controlled trial","volume":"384","author":"Rintoul","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2020.07.017_bib0064","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/JTO.0000000000000499","article-title":"Is radiotherapy useful for treating pain in mesothelioma? A phase II trial","volume":"10","author":"MacLeod","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/annonc\/mdj073","article-title":"A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: The MED trial","volume":"17","author":"O'Brien","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0066","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/thx.54.3.238","article-title":"Percutaneous cervical cordotomy for the control of pain in patients with pleural mesothelioma","volume":"54","author":"Jackson","year":"1999","journal-title":"Thorax"},{"key":"10.1053\/j.jvca.2020.07.017_bib0067","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.1998.16.1.145","article-title":"Prognostic factors in patients with pleural mesothelioma: The European Organization for Research and Treatment of Cancer experience","volume":"16","author":"Curran","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0068","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.113.3.723","article-title":"Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the cancer and leukemia group B","volume":"113","author":"Herndon","year":"1998","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2020.07.017_bib0069","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1097\/JTO.0000000000000661","article-title":"A new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma","volume":"10","author":"Opitz","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1053\/j.jvca.2020.07.017_bib0070","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(08)60727-8","article-title":"Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): A multicentre randomised trial","volume":"371","author":"Muers","year":"2008","journal-title":"Lancet"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077020306479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077020306479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T07:49:30Z","timestamp":1760946570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077020306479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1053077020306479"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2020.07.017","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2019 ERS\/ESTS\/EACTS\/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2020.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}